INTELLIGENT BIO SOLUTIONS INC. (INBS)
2025-06-30 | ||||
|---|---|---|---|---|
| Revenue | 3,052,532 | |||
| Cost of revenue (exclusive of amortization shown separately below) | 1,805,673 | |||
| Gross profit | 1,246,859 | |||
| Government support income | 816,901 | |||
| Impairment of long-lived assets | 220,062 | |||
| Selling, general and administrative expenses | 8,883,917 | |||
| Depreciation and amortization | 1,207,875 | |||
| Development and regulatory approval expenses | 2,396,513 | |||
| Total operating expenses | 12,708,367 | |||
| Loss from operations | -10,644,607 | |||
| Interest income | 101,522 | |||
| Interest expense | 60,890 | |||
| Realized foreign exchange loss | -911 | |||
| Fair value gain on revaluation of financial instrument | - | |||
| Total other income, net | 39,721 | |||
| Net loss | -10,604,886 | |||
| Net loss attributable to non-controlling interest | -36,153 | |||
| Net loss attributable to intelligent bio solutions inc | -10,568,733 | |||
| Net loss per share, basic | -2 | |||
| Net loss per share, diluted | -2 | |||
| Weighted average shares outstanding, basic | 5,273,643 | |||
| Weighted average shares outstanding, diluted | 5,273,643 | |||